Maria S. Neznakhina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria S. Neznakhina has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Irena L. Shlivko
Privolzhsky Research Medical University
6 shared publications - E. V. Krivova
Central State Medical Academy of Department of Presidential Affairs
3 shared publications - Irina A. Klemenova
Privolzhsky Research Medical University
3 shared publications - Kirill I. Kirgizov
Research Institute of Pediatric Oncology and Hematology, FSBI “N.N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of Russia, Kashirskoye sh. 23, Moscow 115522, Russia
3 shared publications - Larisa Sergeevna Kruglova
Central State Medical Academy of the Presidential Executive Office of the Russian Federation
3 shared publications - Marina V. Rubanskaya
N.N. Blokhin National Medical Research Center of Oncology of Ministry of Health of the Russian Federation
3 shared publications
Latest Publications
- 16 March 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (1) , 113-120
Prevention and background therapy of skin toxic reactions in children receiving antitumor drug therapy. Part 2 (results of prospective cohort study)
The success of treatment of childhood malignant tumors is related to the improvement of antitumor drug treatment protocols. However, these agents cause toxicity, most often — skin toxic reactions. Prevention and treatment of dermal toxicity are evolving with emergence of new knowledge about the mechanisms of action of antitumor drugs and understanding of the pathogenesis of drug-induced cutaneous reactions. Objective. To prove the efficacy and safety of the use of background therapy and moisturizers in children receiving systemic drug antitumor treatment. Material and methods. A multicenter prospective observational study, which included 60 patients, was implemented in the L.A. Durnova Research Institute of Children’s Oncology and Hematology of the N.N. Blokhin National Medical Research Center of Oncology for 3 years (October 2022 — October 2025). Patients were divided into 2 groups: receiving background therapy for skin toxic reactions (the 1st group) and combination of background therapy with moisturizing agents (the 2nd group). Median age was 8 years in the 1st group, 9 years in the 2nd. Gender distribution in the 1st group — 43.5% were boys and 56.5% were girls; in the 2nd group — 54.5% and 45.5%, respectively. Results. Statistically significant differences were not found (p=0.16) when comparing functional indicators of the skin in the 1st and 2nd groups, but there was a tendency to a more pronounced improvement in the dynamics of the indicators (reduction of itching, pain sensation and skin dryness) in the 2nd group. Patients of the 2nd group reported a faster regression of skin toxic reactions and a high level of comfort. Conclusion. Prevention and timely monitoring of skin toxic reactions is an integral part of the comprehensive management of patients receiving antitumor therapy. The use of background therapy and moisturizers depending on the severity, as well as the multidisciplinary interaction of oncologist and dermatologist, allow to control the skin toxicity without the need to interrupt vital antitumor treatment.
- 16 March 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (1) , 113-120
Prevention and background therapy of skin toxic reactions in children receiving antitumor drug therapy. Part 2 (results of prospective cohort study)
The success of treatment of childhood malignant tumors is related to the improvement of antitumor drug treatment protocols. However, these agents cause toxicity, most often — skin toxic reactions. Prevention and treatment of dermal toxicity are evolving with emergence of new knowledge about the mechanisms of action of antitumor drugs and understanding of the pathogenesis of drug-induced cutaneous reactions. Objective. To prove the efficacy and safety of the use of background therapy and moisturizers in children receiving systemic drug antitumor treatment. Material and methods. A multicenter prospective observational study, which included 60 patients, was implemented in the L.A. Durnova Research Institute of Children’s Oncology and Hematology of the N.N. Blokhin National Medical Research Center of Oncology for 3 years (October 2022 — October 2025). Patients were divided into 2 groups: receiving background therapy for skin toxic reactions (the 1st group) and combination of background therapy with moisturizing agents (the 2nd group). Median age was 8 years in the 1st group, 9 years in the 2nd. Gender distribution in the 1st group — 43.5% were boys and 56.5% were girls; in the 2nd group — 54.5% and 45.5%, respectively. Results. Statistically significant differences were not found (p=0.16) when comparing functional indicators of the skin in the 1st and 2nd groups, but there was a tendency to a more pronounced improvement in the dynamics of the indicators (reduction of itching, pain sensation and skin dryness) in the 2nd group. Patients of the 2nd group reported a faster regression of skin toxic reactions and a high level of comfort. Conclusion. Prevention and timely monitoring of skin toxic reactions is an integral part of the comprehensive management of patients receiving antitumor therapy. The use of background therapy and moisturizers depending on the severity, as well as the multidisciplinary interaction of oncologist and dermatologist, allow to control the skin toxicity without the need to interrupt vital antitumor treatment.
- 27 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (6)
Prevention and basic therapy of skin toxic reactions in children receiving anti-cancer drug therapy. Part 1
Current protocols of anti-cancer therapy in pediatric oncology demonstrate high efficacy, but their application is often accompanied by development of toxic effects. Skin toxic reactions toxicity occupies one of the leading places in the structure of adverse events of drug treatment, significantly affecting the quality of life of patients and limiting the opportunity to carry out anti-cancer therapy at the scheduled doses and time periods. Skin reactions can be caused by a wide range of anti-cancer drugs, including cytostatics (paclitaxel, methotrexate, cytarabine, doxorubicin), targeted (crizotinib, epidermal growth factor receptor (EGFR) inhibitors) and immunotargeted (dinutuximab, etc.) drugs. Acne-like eruptions, hand-foot syndrome, maculopapular rash, alopecia, itching, xerosis as well as rare but potentially life-threatening bullous dermatoses are the most common manifestations. The article presents data on the spectrum and incidence of adverse dermatological reactions in children receiving modern anti-cancer drugs and considers the role of concomitant therapy in the correction of skin toxic reactions. Timely application of accompanying treatment agents allows to minimize skin damage, accelerate restoration of the skin barrier and increase adherence to anti-cancer treatment. Special attention is given to the preventive measures and treatment of dermatological reactions, which helps to prevent their progression and reduce the risk of forced discontinuation or modification of the background therapy.
- 27 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (6)
Prevention and basic therapy of skin toxic reactions in children receiving anti-cancer drug therapy. Part 1
Current protocols of anti-cancer therapy in pediatric oncology demonstrate high efficacy, but their application is often accompanied by development of toxic effects. Skin toxic reactions toxicity occupies one of the leading places in the structure of adverse events of drug treatment, significantly affecting the quality of life of patients and limiting the opportunity to carry out anti-cancer therapy at the scheduled doses and time periods. Skin reactions can be caused by a wide range of anti-cancer drugs, including cytostatics (paclitaxel, methotrexate, cytarabine, doxorubicin), targeted (crizotinib, epidermal growth factor receptor (EGFR) inhibitors) and immunotargeted (dinutuximab, etc.) drugs. Acne-like eruptions, hand-foot syndrome, maculopapular rash, alopecia, itching, xerosis as well as rare but potentially life-threatening bullous dermatoses are the most common manifestations. The article presents data on the spectrum and incidence of adverse dermatological reactions in children receiving modern anti-cancer drugs and considers the role of concomitant therapy in the correction of skin toxic reactions. Timely application of accompanying treatment agents allows to minimize skin damage, accelerate restoration of the skin barrier and increase adherence to anti-cancer treatment. Special attention is given to the preventive measures and treatment of dermatological reactions, which helps to prevent their progression and reduce the risk of forced discontinuation or modification of the background therapy.
- 10 September 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (4)
Prevention and treatment of dermal toxicity in children receiving anti-tumor radiation
Radiation therapy, being an integral part of malignant neoplasms treatment in children, is unfortunately inevitably accompanied by a high frequency of adverse dermatological reactions. Development of radiodermatitis — from erythema and dryness to oozing lesion, painfulness and ulcerations — is a considerable clinical problem, significantly deteriorates the quality of life of young patients and creates the risk of infectious complications, that could potentially lead to interruptions in life-saving treatment. Critically important is that currently there are almost no randomized controlled studies in the pediatric population specifically devoted to systematic assessment of profile, severity and optimal management of dermatological toxicity caused by radiation therapy. This article focuses on the urgent need and crucial significance of comprehensive supportive skin therapy during and after radiation. Such care includes regular and targeted use of special dermatoprotective products. Moisturizing creams and ointments are designed to combat dryness, desquamation and maintain the integrity of the hydrolipid barrier. Barrier agents (often based on zinc, silicone or special polymers) create a protective film that minimizes friction, mechanical damage and contact with irritants as well as promote healing. The main objectives of this strategy are effective management of clinical manifestations of acute radiodermatitis, maximum possible prevention and minimization of severe skin lesions, as well as significant acceleration of their recovery and re-epithelization processes in the post-radiation period. The obtained results and collated recommendations are of significant practical interest to a wide range of specialists — dermatologists, pediatric oncologists, pediatricians and radiotherapists, who directly comprehensively treat children with malignant tumors, undergoing radiation therapy, and strive to optimize their treatment tolerability and quality of life.
- 10 September 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (4)
Prevention and treatment of dermal toxicity in children receiving anti-tumor radiation
Radiation therapy, being an integral part of malignant neoplasms treatment in children, is unfortunately inevitably accompanied by a high frequency of adverse dermatological reactions. Development of radiodermatitis — from erythema and dryness to oozing lesion, painfulness and ulcerations — is a considerable clinical problem, significantly deteriorates the quality of life of young patients and creates the risk of infectious complications, that could potentially lead to interruptions in life-saving treatment. Critically important is that currently there are almost no randomized controlled studies in the pediatric population specifically devoted to systematic assessment of profile, severity and optimal management of dermatological toxicity caused by radiation therapy. This article focuses on the urgent need and crucial significance of comprehensive supportive skin therapy during and after radiation. Such care includes regular and targeted use of special dermatoprotective products. Moisturizing creams and ointments are designed to combat dryness, desquamation and maintain the integrity of the hydrolipid barrier. Barrier agents (often based on zinc, silicone or special polymers) create a protective film that minimizes friction, mechanical damage and contact with irritants as well as promote healing. The main objectives of this strategy are effective management of clinical manifestations of acute radiodermatitis, maximum possible prevention and minimization of severe skin lesions, as well as significant acceleration of their recovery and re-epithelization processes in the post-radiation period. The obtained results and collated recommendations are of significant practical interest to a wide range of specialists — dermatologists, pediatric oncologists, pediatricians and radiotherapists, who directly comprehensively treat children with malignant tumors, undergoing radiation therapy, and strive to optimize their treatment tolerability and quality of life.
- Open Access
- 10 June 2025
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 101 (2) , 87-93
Onychodystrophies: possibilities of topical therapy
Nail plates are visually significant areas of the body and not only protect the distal phalanges from mechanical damage, but also determine the aesthetic appeal of the hands and feet. Patients with pathological changes in the nails experience not only physical discomfort, but also severe emotional suffering. This determines the search for the most effective methods of treating onychodystrophies. Practitioners are provided with modern information on the etiology, pathogenesis, clinical features of various types of onychodystrophies, therapeutic approaches and methods of local treatment. It is shown that hydration of the nail plate leads to increased permeability of drugs. The use of water-soluble chitosan and other active substances in the treatment of onychodystrophies is justified. As a result of a multicenter observational prospective study to assess the efficacy, safety and tolerability of Klavio lotions for the treatment of non-infectious onychodystrophies of the hands and feet of various etiologies, the effectiveness of these products is demonstrated.
- 10 June 2025
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 101 (2) , 87-93
Open AccessOnychodystrophies: possibilities of topical therapy
Nail plates are visually significant areas of the body and not only protect the distal phalanges from mechanical damage, but also determine the aesthetic appeal of the hands and feet. Patients with pathological changes in the nails experience not only physical discomfort, but also severe emotional suffering. This determines the search for the most effective methods of treating onychodystrophies. Practitioners are provided with modern information on the etiology, pathogenesis, clinical features of various types of onychodystrophies, therapeutic approaches and methods of local treatment. It is shown that hydration of the nail plate leads to increased permeability of drugs. The use of water-soluble chitosan and other active substances in the treatment of onychodystrophies is justified. As a result of a multicenter observational prospective study to assess the efficacy, safety and tolerability of Klavio lotions for the treatment of non-infectious onychodystrophies of the hands and feet of various etiologies, the effectiveness of these products is demonstrated.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (4)
Algorithm of management of pink skin neoplasms in children
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (4)
Algorithm of management of pink skin neoplasms in children
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (1)
Follicular lichen ruber planus induced by occupational factors
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (1)
Follicular lichen ruber planus induced by occupational factors
- Open Access
- 30 July 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 9,p. 102-120
Non-invasive diagnostic techniques for skin tumors and their potential for use in skin melanoma screening: a systematic literature review
Introduction.Currently, numerous studies are published by authors of different countries to demonstrate the effectiveness of noninvasive methods in the diagnosis of melanoma.Methods.A systematic search was conducted independently in the databases PubMed and Cochrane Central Register of Controlled Trials (CENTRAL) until April 2020 according to certain inclusion criteria. Data extraction was carried out independently, followed by generalization using descriptive tables. Due to the heterogeneity of the included studies and the impossibility of carrying out a meta-analysis in view of this, we performed a narrative description.Results.A total of 765 potential publications for inclusion were found and checked, of which 53 were included. By design, the studies were assigned to studies of simultaneous design – 40, to randomized clinical trials – 7, to meta-analysis – 6. Data in the included publications on 76802 skin neoplasms were reported, of which 9070 were melanomas. The extracted data were summarized in descriptive tables.Conclusion.With continuing technological progress, the development of noninvasive imaging technologies in the diagnosis of skin melanoma should follow the path of cost-effective, simple and accurate diagnosis.
- 30 July 2020
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 9,p. 102-120
Open AccessNon-invasive diagnostic techniques for skin tumors and their potential for use in skin melanoma screening: a systematic literature review
Introduction.Currently, numerous studies are published by authors of different countries to demonstrate the effectiveness of noninvasive methods in the diagnosis of melanoma.Methods.A systematic search was conducted independently in the databases PubMed and Cochrane Central Register of Controlled Trials (CENTRAL) until April 2020 according to certain inclusion criteria. Data extraction was carried out independently, followed by generalization using descriptive tables. Due to the heterogeneity of the included studies and the impossibility of carrying out a meta-analysis in view of this, we performed a narrative description.Results.A total of 765 potential publications for inclusion were found and checked, of which 53 were included. By design, the studies were assigned to studies of simultaneous design – 40, to randomized clinical trials – 7, to meta-analysis – 6. Data in the included publications on 76802 skin neoplasms were reported, of which 9070 were melanomas. The extracted data were summarized in descriptive tables.Conclusion.With continuing technological progress, the development of noninvasive imaging technologies in the diagnosis of skin melanoma should follow the path of cost-effective, simple and accurate diagnosis.